Literature DB >> 922327

Maternal drug histories and congenital abnormalities.

G Greenberg, W H Inman, J A Weatherall, A M Adelstein, J C Haskey.   

Abstract

We obtained drug histories for the first trimester of pregnancy for 836 mothers of congenitally malformed babies and for an equal number of control mothers of normal babies from the same doctors' practices. There was an association between the use of a hormonal pregnancy test and the subsequent birht of a malformed baby. There was also a greater use of barbiturates by mothers of affected children compared with mothers of control babies, mainly accounted for by treatment of epileptic mothers with phenobarbitone. For all other drugs usage was similar in both sets of mothers.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 922327      PMCID: PMC1631672          DOI: 10.1136/bmj.2.6091.853

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  10 in total

1.  Antenatal exposure to meprobamate and chlordiazepoxide in relation to malformations, mental development, and childhood mortality.

Authors:  S C Hartz; O P Heinonen; S Shapiro; V Siskind; D Slone
Journal:  N Engl J Med       Date:  1975-04-03       Impact factor: 91.245

2.  Effects of prenatal meprobamate and chlordiazepoxide hydrochloride on human embryonic and fetal development.

Authors:  L Milkovich; B J van den Berg
Journal:  N Engl J Med       Date:  1974-12-12       Impact factor: 91.245

3.  Hormone treatment during pregnancy and congenital heart defects.

Authors:  E P Levy; A Cohen; F C Fraser
Journal:  Lancet       Date:  1973-03-17       Impact factor: 79.321

4.  Birth defects and oral contraceptives.

Authors:  J J Nora; A H Nora
Journal:  Lancet       Date:  1973-04-28       Impact factor: 79.321

5.  Oral contraceptives and congenital limb-reduction defects.

Authors:  D T Janerich; J M Piper; D M Glebatis
Journal:  N Engl J Med       Date:  1974-10-03       Impact factor: 91.245

6.  Hormonal pregnancy tests and neural tube malformations.

Authors:  M Laurence; M Miller; M Vowles; K Evans; C Carter
Journal:  Nature       Date:  1971-10-15       Impact factor: 49.962

7.  Hormonal pregnancy tests and congenital malformation.

Authors:  I Gal; B Kirman; J Stern
Journal:  Nature       Date:  1967-10-07       Impact factor: 49.962

8.  Anticonvulsants and parental epilepsy in the development of birth defects.

Authors:  S Shapiro; S C Hartz; V Siskind; A A Mitchell; D Slone; L Rosenberg; R R Monson; O P Heinonen
Journal:  Lancet       Date:  1976-02-07       Impact factor: 79.321

9.  Association between cleft lip with or without cleft palate and prenatal exposure to diazepam.

Authors:  M J Safra; G P Oakley
Journal:  Lancet       Date:  1975-09-13       Impact factor: 79.321

10.  Congenital heart disease and prenatal exposure to exogenous sex hormones.

Authors:  D T Janerich; J M Dugan; S J Standfast; L Strite
Journal:  Br Med J       Date:  1977-04-23
  10 in total
  17 in total

1.  Prescribing in pregnancy. Identifying abnormalities.

Authors:  M J Whittle; K P Hanretty
Journal:  Br Med J (Clin Res Ed)       Date:  1986-12-06

2.  The Impact of Oral Intake of Dydrogesterone on Fetal Heart Development During Early Pregnancy.

Authors:  Mahmoud Zaqout; Emad Aslem; Mazen Abuqamar; Osama Abughazza; Joseph Panzer; Daniel De Wolf
Journal:  Pediatr Cardiol       Date:  2015-05-15       Impact factor: 1.655

Review 3.  A risk-benefit assessment of pharmacological and nonpharmacological treatments for nausea and vomiting of pregnancy.

Authors:  P Mazzotta; L A Magee
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

4.  The debendox saga.

Authors:  M L Orme
Journal:  Br Med J (Clin Res Ed)       Date:  1985-10-05

Review 5.  Adverse effects of antianxiety drugs.

Authors:  J G Edwards
Journal:  Drugs       Date:  1981-12       Impact factor: 9.546

6.  Maternal drug histories and congenital abnormalities.

Authors:  N Sethi; M Manchanda; M Sharma
Journal:  Indian J Pediatr       Date:  1979-11       Impact factor: 1.967

7.  Continued use of hormonal pregnancy test.

Authors:  C Brewer
Journal:  Br Med J       Date:  1978-02-18

Review 8.  Treating allergic rhinitis in pregnancy. Safety considerations.

Authors:  P Mazzotta; R Loebstein; G Koren
Journal:  Drug Saf       Date:  1999-04       Impact factor: 5.606

9.  Maternal drug histories and congenital malformations: limb reduction defects and oral clefts.

Authors:  L Hill; M Murphy; M McDowall; A H Paul
Journal:  J Epidemiol Community Health       Date:  1988-03       Impact factor: 3.710

Review 10.  Management of epilepsy during pregnancy.

Authors:  Dina Battino; Torbjörn Tomson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.